Clinical Trials Logo
  1. Home
  2. Solid Organ Transplant
  3. NCT05968807

iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients

Solid Organ Transplant Clinical Trial

Official title:
"The Isolation I Feel is Profound": The iParent2Parent Online Peer Support Program for Parents of Pediatric Solid Organ Transplantation Recipients

Clinical Trial Summary

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05968807
Study type Interventional
Source The Hospital for Sick Children
Contact Samantha J. Anthony, PhD, MSW
Phone 416-813-7654
Email samantha.anthony@sickkids.ca
Status Recruiting
Phase N/A
Start date August 1, 2023
Completion date June 26, 2026
View Details
See also
  Status Clinical Trial Phase
Terminated NCT03950414 - A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients Phase 1
Recruiting NCT05663463 - Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients N/A
Completed NCT05124509 - Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
Completed NCT05121142 - Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease Phase 1
Completed NCT01058239 - Bortezomib Plus Rituximab for EBV+ PTLD Phase 2
Withdrawn NCT03327987 - Early Flu Shots in SOT
Completed NCT04253548 - iPeer2Peer Pediatric Thoracic Transplantation N/A
Recruiting NCT05164016 - Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Withdrawn NCT02464306 - Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection Phase 4
Completed NCT02165423 - Discharge to Home and Chronic Illness Care Pilot N/A
Completed NCT00907023 - Transition From Hospital to Home in Solid Organ Transplant (SOT) N/A
Recruiting NCT04613206 - High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients Phase 2
Recruiting NCT05550298 - Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Completed NCT00518778 - Fusariosis in Solid-Organ Transplant Recipients N/A
Active, not recruiting NCT04331275 - Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant Phase 2
Active, not recruiting NCT03482739 - Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients Phase 3
Not yet recruiting NCT04721288 - REmote moBile Outpatient mOnitoring in Transplant 2.0 N/A
Completed NCT04844489 - Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People N/A
Active, not recruiting NCT03360682 - Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients Phase 4